Dae Hyun Yoo Selected Research

Dae Hyun Yoo Research Topics

Disease

30	Rheumatoid Arthritis 01/2024 - 10/2013
6	Ankylosing Spondylitis 06/2020 - 10/2013
4	Tuberculosis (Tuberculoses) 03/2021 - 07/2013
2	Myositis (Idiopathic Inflammatory Myopathies) 09/2023 - 09/2020
2	Infections 09/2023 - 01/2021
2	Herpes Zoster 01/2023 - 01/2022
2	Adult-Onset Still's Disease 02/2021 - 02/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2017 - 01/2016
2	Systemic Scleroderma (Systemic Sclerosis) 09/2017 - 04/2006
2	Necrosis 03/2017 - 07/2013
1	Soft Tissue Infections 09/2023
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2023
1	Dermatomyositis (Dermatopolymyositis) 09/2023
1	Opportunistic Infections (Opportunistic Infection) 09/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Leukocytosis (Pleocytosis) 02/2021
1	Pleurisy (Pleuritis) 02/2021
1	Hyperferritinemia 02/2021
1	Pneumonia (Pneumonitis) 02/2021
1	Joint Diseases (Joint Disease) 11/2019
1	Lupus Nephritis 05/2018
1	Proteinuria 05/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Pleural Effusion (Pleural Effusions) 09/2017
1	Diabetes Mellitus 09/2017
1	Arthritis (Polyarthritis) 01/2017
1	Macrophage Activation Syndrome 01/2017
1	Disease Progression 01/2017
1	Pain (Aches) 12/2014
1	Osteoarthritis 12/2014
1	Autoimmune Diseases (Autoimmune Disease) 07/2013
1	Inflammation (Inflammations) 07/2003
1	Colonic Neoplasms (Colon Cancer) 07/2003
1	Insulin Resistance 07/2003
1	Chronic Hepatitis B 02/2002
1	Cardiomyopathies (Cardiomyopathy) 02/2002
1	Hepatitis B 02/2002
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 02/2002
1	Polymyositis 02/2002
1	Muscle Weakness 02/2002

Drug/Important Bio-Agent (IBA)

17	Biosimilar PharmaceuticalsIBA 07/2023 - 10/2013
13	Infliximab (Remicade)FDA Link 01/2023 - 10/2013
13	CT-P13IBA 01/2021 - 10/2013
8	Rituximab (Mabthera)FDA Link 12/2020 - 01/2017
7	CT-P10IBA 12/2020 - 01/2017
5	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 07/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2024 - 01/2016
2	SteroidsIBA 09/2023 - 02/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017 - 11/2015
2	AntibodiesIBA 03/2015 - 10/2013
1	Abatacept (Orencia)FDA Link 01/2024
1	Amino Acids FDA Link 01/2024
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2023
1	tofacitinibIBA 01/2023
1	Janus Kinase InhibitorsIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 02/2021
1	InterleukinsIBA 02/2021
1	Adalimumab (Humira)FDA Link 01/2021
1	Etanercept (Enbrel)FDA Link 01/2021
1	Monoclonal AntibodiesIBA 09/2020
1	baricitinibIBA 01/2020
1	Interleukin-6 InhibitorsIBA 11/2019
1	Interleukin-1 (Interleukin 1)IBA 11/2019
1	CreatinineIBA 05/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2018
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 05/2018
1	Carbon MonoxideIBA 09/2017
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 09/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	HLA-DR beta-ChainsIBA 01/2016
1	Peptides (Polypeptides)IBA 03/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2014
1	EtoricoxibIBA 12/2014
1	Celecoxib (Celebrex)FDA Link 12/2014
1	Antirheumatic Agents (DMARD)IBA 08/2014
1	Methotrexate (Mexate)FDA LinkGeneric 10/2013
1	Interferon-gamma (Interferon, gamma)IBA 07/2013
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2006
1	PPAR-gamma AgonistsIBA 07/2003
1	PPAR gammaIBA 07/2003
1	InterferonsIBA 02/2002
1	Intravenous Immunoglobulins (IVIG)FDA Link 02/2002
1	Interferon-alpha (Interferon Alfa)IBA 02/2002
1	Immunoglobulins (Immunoglobulin)IBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2023 - 05/2018
1	Biological Therapy 08/2017